Key result
Durvalumab monotherapy induced acute immune-mediated myocarditis in a 67-year-old male with lung squamous cell carcinoma, which rapidly resolved following glucocorticoid treatment.
Why the study?
Myocarditis following PD-L1 inhibitor therapy is characterized by low incidence and high mortality.
Does durvalumab monotherapy cause acute myocarditis in patients with lung squamous cell carcinoma?
Case Report (n=1)
Does durvalumab monotherapy cause acute myocarditis in patients with lung squamous cell carcinoma?
Durvalumab monotherapy can cause acute, potentially fatal immune-mediated myocarditis that may respond rapidly to glucocorticoid therapy.
Answers are grounded in this paper and cite their sources.
Durvalumab may trigger immune-mediated myocarditis; case supports glucocorticoid response but leaves optimal surveillance open.
Background: Durvalumab, as a PD-L1 inhibitor, is commonly used for the treatment of various cancers. Adverse events associated with the therapy include hepatitis, nephritis, dermatitis, and myocarditis. Especially, myocarditis as an adverse event after PD-L1 inhibitor therapy is characterized for its low incidence and high mortality. Case Summary: Here we present a rare case of a 67-year-old male with lung squamous cell carcinoma complicated with empyema who experienced myocarditis after only PD-L1 inhibitor durvalumab monotherapy. He presented with markedly decrease left ventricular ejection fraction, elevated Natriuretic peptide BNP, Troponin T, Troponin I, ESR, CRP and interleukin-6. The electrocardiogram showed sinus tachycardia, low voltage of limb leads, T wave inversion in anterior waves and V1-V3 QS type. Myocardial injury occurred in a short period and quickly returned to normal after glucocorticoids therapy. Conclusion: This case report is of clinical value for the treatment of PD-L1 related myocarditis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2022) conducted a case report in Lung squamous cell carcinoma (n=1). Durvalumab was evaluated. Durvalumab monotherapy induced acute immune-mediated myocarditis in a 67-year-old male with lung squamous cell carcinoma, which rapidly resolved following glucocorticoid treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: